• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evaluation of the point-of-care Becton Dickinson Veritor? Rapid influenza diagnostic test in Kenya, 2013-2014

tetano

Editor, Senior Moderator
BMC Infect Dis. 2017 Jan 11;17(1):60. doi: 10.1186/s12879-016-2131-9.
[h=1]Evaluation of the point-of-care Becton Dickinson Veritor? Rapid influenza diagnostic test in Kenya, 2013-2014.[/h] Ndegwa LK[SUP]1,[/SUP][SUP]2[/SUP], Emukule G[SUP]3[/SUP], Uyeki TM[SUP]4[/SUP], Mailu E[SUP]5[/SUP], Chaves SS[SUP]3[/SUP], Widdowson MA[SUP]3[/SUP], Lewa BV[SUP]6[/SUP], Muiruri FK[SUP]7[/SUP], Omoth P[SUP]8[/SUP], Fields B[SUP]3[/SUP], Mott JA[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] We evaluated the performance of the Becton Dickinson Veritor? System Flu A + B rapid influenza diagnostic test (RIDT) to detect influenza viruses in respiratory specimens from patients enrolled at five surveillance sites in Kenya, a tropical country where influenza seasonality is variable.
[h=4]METHODS:[/h] Nasal swab (NS) and nasopharyngeal (NP)/oropharyngeal (OP) swabs were collected from patients with influenza like illness and/or severe acute respiratory infection. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the RIDT using NS specimens were evaluated against nasal swabs tested by real time reverse transcription polymerase chain reaction (rRT-PCR). The performance parameter results were expressed as 95% confidence intervals (CI) calculated using binomial exact methods, with P < 0.05 considered significant. Two-sample Z tests were used to test for differences in sample proportions. Analysis was performed using SAS software version 9.3.
[h=4]RESULTS:[/h] From July 2013 to July 2014, 3,569 patients were recruited, of which 78.7% were aged <5 years. Overall, 14.4% of NS specimens were influenza-positive by RIDT. RIDT overall sensitivity was 77.1% (95% CI 72.8-81.0%) and specificity was 94.9% (95% CI 94.0-95.7%) compared to rRT-PCR using NS specimens. RIDT sensitivity for influenza A virus compared to rRT-PCR using NS specimens was 71.8% (95% CI 66.7-76.4%) and was significantly higher than for influenza B which was 43.8% (95% CI 33.8-54.2%). PPV ranged from 30%-80% depending on background prevalence of influenza.
[h=4]CONCLUSION:[/h] Although the variable seasonality of influenza in tropical Africa presents unique challenges, RIDTs may have a role in making influenza surveillance sustainable in more remote areas of Africa, where laboratory capacity is limited.


[h=4]KEYWORDS:[/h] Influenza; Kenya; Rapid influenza test; Sensitivity and specificity

PMID: 28077093 DOI: 10.1186/s12879-016-2131-9
[PubMed - in process] Free full text
 
Back
Top Bottom